Medtech Trends Shaping Future Growth: From VBP to Platform Competition

Executive Summary

The medical technology sector is undergoing rapid structural shifts, driven by evolving regulatory frameworks, changing clinical practice models, and technological integration. This analysis examines five critical trends that are redefining market economics and business strategy within medtech.

• Mainland China’s Volume-Based Procurement (VBP) Expansion: This mechanism is moving beyond simple patient access to become a sophisticated market-structuring tool, influencing pricing expectations and competitive positioning for multinational companies.
• Shift to Outpatient and ASC Settings: Regulatory changes are accelerating the migration of procedures from hospitals to Ambulatory Surgery Centers (ASCs), demanding that medtech companies adapt product design and commercial models for diverse service environments.
• Supply Chain and Manufacturing Realignment: Geopolitical risks and cost volatility are forcing manufacturers to prioritize supply chain resilience through sourcing diversification and investment in scalable manufacturing footprints.
• GLP-1 Therapy Impact: The widespread adoption of GLP-1 receptor agonists is altering patient behavior, creating new referral patterns and generating ripple effects across adjacent device markets and clinical pathways.
• Platform-Based Competition: The integration of enabling technologies like robotics and digital workflow software is fostering a competitive environment where platform architectures become central to value creation and customer engagement.

Introduction

The medtech landscape is entering a phase of accelerated change where structural forces across pricing, care delivery, supply chains, and clinical pathways are dictating market dynamics. Understanding these trends is crucial for assessing investment significance and industrial competitiveness in the region.

Main Analysis

#### 1. Mainland China’s VBP Expansion Redefining Global Market Economics Mainland China's national volume-based procurement (VBP) round is evolving into a powerful market-structuring mechanism. By introducing refined anchor-price logic and allocation systems, this program is not merely about expanding patient access; it is actively reshaping domestic manufacturing strategies and influencing expectations regarding price and volume for multinational medtech firms operating in the region.

#### 2. Outpatient and ASC Settings as the New Standard
Regulatory shifts, such as those outlined in the U.S. Centers for Medicare & Medicaid Services (CMS) rules, are encouraging the migration of eligible procedures from inpatient facilities to outpatient settings and Ambulatory Surgery Centers (ASCs). This transition requires medtech manufacturers to re-evaluate their product designs and commercial value propositions to cater to a more diverse and lower-cost service delivery model.

#### 3. Supply Chain Resilience as a Strategic Imperative
Geopolitical instability and material cost fluctuations have made supply chain resilience a primary strategic consideration. Companies are moving away from single-source dependencies, emphasizing multi-region manufacturing footprints and increased investment in integrated technologies to buffer against global volatility.

#### 4. The Influence of GLP-1 Therapies on Care Pathways
The rapid uptake of GLP-1 receptor agonists is fundamentally altering patient behavior related to weight management and comorbidities. This clinical shift is creating new referral patterns, generating downstream demand across various Medtech categories, including diabetes care and cardiovascular monitoring devices.

#### 5. Enabling Technologies Driving Platform Competition
Enabling technologies, including robotics, advanced imaging, and digital workflow software, are moving from supportive roles to central components of the service delivery ecosystem. This trend favors companies developing platform architectures that can integrate various services, creating new competitive dynamics based on ecosystem strength rather than just individual product performance.

Regional Impact

Economic Growth and Industrial Development: The trends suggest an acceleration in industrial development, particularly in areas supporting outpatient care and advanced manufacturing capabilities. Increased focus on scalable solutions and supply chain diversification will influence where manufacturing capacity is established.

Regional Competitiveness: Companies that successfully adapt their business models to navigate VBP complexities and adopt platform strategies are better positioned to maintain competitiveness in the evolving global market.

Foreign Direct Investment (FDI): Investment will likely flow toward regions offering robust infrastructure for advanced manufacturing, strong regulatory clarity, and access to emerging technologies like digital health platforms.

Technology Adoption: There is a clear trend toward adopting integrated technologies—robotics, AI-driven diagnostics, and digital workflow software—to improve clinical outcomes and operational efficiency.

Supply Chain Resilience: The push for diversification implies increased investment in regional supply chain nodes, potentially leading to the development of localized manufacturing ecosystems.

Regional Cooperation: Collaboration on standardizing regulatory pathways and developing shared technological platforms could become increasingly important for regional Medtech players to enhance collective market access and innovation.

Strategic Insights

Business Opportunities: Opportunities exist in developing integrated platform solutions that leverage enabling technologies to anchor service lines. Furthermore, companies specializing in supply chain optimization and scalable manufacturing processes are well-positioned to capture market share amid volatility.

Corporate Strategy: Corporate strategy must pivot toward ecosystem building. This involves moving beyond product-centric development to creating interconnected service platforms that secure customer relationships and unlock data-driven value propositions.

Investment Implications: Investment should be directed toward firms demonstrating agility in navigating complex regulatory environments (like VBP) and those investing strategically in enabling technologies that facilitate platform-based competition.

Policy Priorities: Policymakers must focus on creating regulatory frameworks that support the safe and efficient adoption of new technologies, while also fostering infrastructure that supports scalable, resilient manufacturing and regional supply chain networks.

Emerging Industries: The convergence of digital health, advanced manufacturing, and personalized medicine driven by GLP-1 therapy effects represents a fertile ground for new Medtech niches.

Competitive Risks: The primary risks include regulatory shifts that could rapidly alter market access and the failure to secure resilient, diversified supply chains amidst geopolitical pressures.

Future Outlook

Over the next three to five years, the medtech sector is expected to see deeper integration of digital technologies. Artificial Intelligence will play a pivotal role in optimizing clinical pathways, enhancing diagnostic accuracy, and managing complex supply chains. The digital economy will drive the adoption of platform-based competition, where data and integrated software define market position. Infrastructure investments in advanced manufacturing and digital connectivity will be critical enablers.

Regional cooperation will intensify, focusing on shared standards, cross-border data flows for clinical research, and joint efforts to build resilient supply chains. South Asia's global competitiveness in Medtech will depend on its ability to strategically integrate emerging technologies while managing complex, evolving supply chain and regulatory landscapes.

Conclusion

The medtech sector is defined by structural shifts demanding strategic adaptation. Success in the coming years will depend not just on technological advancement but on the ability of businesses and policymakers to anticipate market restructuring, invest in resilient ecosystems, and embrace platform-based competition.